Healthcare / Health Information ServicesTokyo
$10340.00
+30.00 (+0.29%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $5.4B · quality 51.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
39/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$51.1B
P/E
8.9x
↓EV/EBITDA
4.1x
↓ROE
14.6%
↑Gross Margin
26.8%
↓Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+15.3%
FCF CAGR
+46.7%
FCF margin
6.3%
FCF / Net income
0.44x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $42.30B · net income $6.11B · FCF $2.66B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $42.30B | $42.30B | $38.42B | $33.72B | $27.57B |
| Net Income | $6.11B | $6.11B | $5.33B | $4.86B | $3.40B |
| EBITDA | $9.27B | $9.27B | $7.93B | $7.16B | $5.25B |
| EPS | 1167.88 | 1167.88 | 1018.92 | 930.35 | 628.54 |
| Gross Margin | 26.8% | 26.8% | 26.0% | 27.2% | 26.5% |
| Operating Margin | 19.8% | 19.8% | 18.9% | 19.3% | 17.6% |
| Net Margin | 14.4% | 14.4% | 13.9% | 14.4% | 12.3% |
| Balance Sheet | |||||
| Debt/Equity | — | — | — | — | 0.00 |
| Current Ratio | 3.40 | 3.40 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.66B | $2.66B | $7.05B | $5.36B | $843.9M |
| Returns | |||||
| ROE | 14.6% | 14.6% | 14.6% | 15.4% | 12.5% |
| Valuation | |||||
| P/E | 8.85 | 8.85 | 13.21 | 9.81 | 13.49 |
| EV/EBITDA | 4.09 | 4.09 | 6.95 | 5.15 | 7.75 |
| P/B | 1.29 | 1.29 | 1.93 | 1.51 | 1.68 |
| Growth & Yield | |||||
| Revenue Growth | 10.1% | 10.1% | 14.0% | 22.3% | — |
| EPS Growth | 14.6% | 14.6% | 9.5% | 48.0% | — |
| Dividend Yield | 1.7% | 1.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-7.7%
EPS terminal req.
$917.50
Spread vs growth
22.3%
5Y implied EPS CAGR
-1.0%
EPS terminal req.
$1110.18
Spread vs growth
15.6%
10Y implied EPS CAGR
4.4%
EPS terminal req.
$1787.95
Spread vs growth
10.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-14.2%
Start / end P/E
12.1x → 8.9x
EPS bridge
1018.92 → 1167.88
Residual
-3.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.